Jose Manuel Valdivielso Revilla

Montserrat-Capdevila, J; Seminario, MA; Godoy, P; Marsal, JR; Ortega, M; Pujol, J; Castan, MT; Alseda, M; Betriu À; Lecube, A; Portero, M; Purroy, F; Valdivielso, JM; Barbe, F

Prevalence of chronic obstructive pulmonary disease (COPD) not diagnosed in a population with cardiovascular risk factors

MEDICINA CLINICA 151 383-389. 21/11/2018.

[doi:10.1016/j.medcli.2017.12.018]

Arcidiacono, MV; Rimondi, E; Maietti, E; Melloni, E; Tisato, V; Gallo, S; Valdivielso, JM; Fernandez, E; Betriu À; Voltan, R; Zauli, G; Volpato, S; Secchiero, P

Relationship between low levels of circulating TRAIL and atheromatosis progression in patients with chronic kidney disease

PLOS ONE 13 -. 11/09/2018.

[doi:10.1371/journal.pone.0203716]

Palanca, A; Castelblanco, E; Perpinan, H; Betriu, A; Soldevila, B; Valdivielso, JM; Bermudez, M; Duran, X; Fernandez, E; Puig-Domingo, M; Groop, PH; Alonso, N; Mauricio, D

Prevalence and progression of subclinical atherosclerosis in patients with chronic kidney disease and diabetes

Atherosclerosis 276 50-57. 01/09/2018.

[doi:10.1016/j.atherosclerosis.2018.07.018]

Sans, MB; Perez-Fontan, M; Martinez-Alonso, M; Bajo, A; Betriu, A; Valdivielso, JM; Fernandez, E; NEFRONA Investigators

The modality of dialysis does not influence atheromatous vascular disease progression or cardiovascular outcomes in dialysis patients without previous cardiovascular disease (vol 12, e0186921, 2017)

PLOS ONE 13 -. 28/06/2018.

[doi:10.1371/journal.pone.0200226]

Caus, Maite; Bozic, Milica; Fernandez, Elvira; Valdivielso, Jose M.

DELETION OF VITAMIN D RECEPTOR EXCLUSIVELY IN VASCULAR SMOOTH MUSCLE CELLS PREVENTS VASCULAR CALCIFICATION

NEPHROLOGY DIALYSIS TRANSPLANTATION 33 159-159. 01/05/2018.

Crespo-Masip, M; Perez, A; Garcia, A; Munoz-Castaneda, JR; Rodriguez, JM; Fernandez, E; Valdivielso, JM

PTEN INDUCIBLE KO MICE SHOW ALTERED MINERAL METABOLISM

NEPHROLOGY DIALYSIS TRANSPLANTATION 33 -. 01/05/2018.

Palau, V; Riera, M; Benito, D; Duran, X; Valdivielso, JM; Betriu, MA; Fernandez, E; Pascual, J; Soler, MJ

CIRCULATING ADAM17 ACTIVITY AS A MARKER OF CV EVENTS IN CKD PATIENTS

NEPHROLOGY DIALYSIS TRANSPLANTATION 33 131-131. 01/05/2018.

Palau, V; Riera, M; Benito, D; Duran, X; Valdivielso, JM; Rodriguez, E; Betriu, MA; Fernandez, E; Pascual, J; Soler, MJ

ROLE OF CIRCULATING ADAM17 ACTIVITY IN CHRONIC KIDNEY DISEASE

NEPHROLOGY DIALYSIS TRANSPLANTATION 33 46-46. 01/05/2018.

Bozic M; Betriu A; Bermudez-Lopez M; Ortiz A; Fernandez E; Valdivielso JM

Association of FGF-2 Concentrations with Atheroma Progression in Chronic Kidney Disease Patients

Clinical Journal Of The American Society Of Nephrology 13 577-584. 06/04/2018.

[doi:10.2215/CJN.07980717]

Bozic M; Méndez-Barbero N; Gutiérrez-Muñoz C; Betriu A; Egido J; Fernández E; Martín-Ventura JL; Valdivielso JM; Blanco-Colio LM

Combination of biomarkers of vascular calcification and sTWEAK to predict cardiovascular events in chronic kidney disease

Atherosclerosis 270 13-20. 01/03/2018.

[doi:10.1016/j.atherosclerosis.2018.01.011]

Bermudez-Lopez, M; Betriu À; Valdivielso, JM; Bretones Del Pino T; Arroyo, D; Fernandez, E

Beyond the traditional lipid parameters in chronic kidney disease

Nefrologia 38 109-113. 01/03/2018.

[doi:10.1016/j.nefro.2017.09.008]

Rayego-Mateos, S; Rodrigues-Diez, R; Morgado-Pascual, JL; Valentijn, F; Valdivielso, JM; Goldschmeding, R; Ruiz-Ortega, M

Role of Epidermal Growth Factor Receptor (EGFR) and Its Ligands in Kidney Inflammation and Damage

Mediators of Inflammation 2018 8739473-8739473. 01/01/2018.

[doi:10.1155/2018/8739473]